Madrigal Pharmaceuticals (MDGL) Insider buying
5 open-market purchases of MDGL by Madrigal Pharmaceuticals's executives and directors since November 2026, worth $35M in total, from SEC Form 4 filings.
Summary
The most recent: Baker Bros. Advisors Lp, Director bought $23M on November 6, 2026.
The biggest buyer over the period is Baker Bros. Advisors Lp (Director): 5 purchases, $35M.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 5 | $35M |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Baker Bros. Advisors Lp Director | 5 | $35M |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Nov 6, 2026 | Baker Bros. Advisors Lp Director |
60,400 | $383.01 | $23M | Form 4 |
| Nov 6, 2026 | Baker Bros. Advisors Lp Director |
13,740 | $388.29 | $5M | Form 4 |
| Nov 6, 2026 | Baker Bros. Advisors Lp Director |
2,000 | $396.61 | $793,220 | Form 4 |
| Nov 4, 2026 | Baker Bros. Advisors Lp Director |
5,586 | $366.99 | $2M | Form 4 |
| Nov 4, 2026 | Baker Bros. Advisors Lp Director |
10,080 | $368.11 | $4M | Form 4 |
Questions about Madrigal Pharmaceuticals
Are Madrigal Pharmaceuticals insiders buying the stock?
5 open-market purchases of MDGL by Madrigal Pharmaceuticals's executives and directors since November 2026, worth $35M in total, from SEC Form 4 filings. The most recent: Baker Bros. Advisors Lp, Director bought $23M on November 6, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From Madrigal Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.